Look for any podcast host, guest or anyone
Showing episodes and shows of

Dr Robert Hess

Shows

435 Podcast: Southern Utah435 Podcast: Southern UtahWho Really Controls Your Neighborhood?Send us a textDive into the intricacies of Utah's 2025 legislative session with Washington City's Legislative Affairs Director Jordan Hess as he breaks down the bills that will reshape Southern Utah's communities. With over 582 bills passed during this session, Jordan helps navigate the complex political landscape while offering unique insights from his perspective working directly with lawmakers and municipalities.Jordan Hess unpacks controversial legislation like the flag display restrictions in public buildings, enhanced enforcement capabilities against illegal short-term rentals, and new voter integrity measures requiring additional verification for mail-in ballots.The discussion takes...2025-03-251h 15The MycoGeeky PodcastThe MycoGeeky PodcastThe Minds Behind Spore Works: John Workman, Robert Hess, and the APE Cultigen That Changed MycologySend us a text📢 Exclusive Alert: This is only the second-ever recorded interview given by John Workman, co-founder of Spore Works, and it’s a MycoGeeky Podcast exclusive!Discover the incredible story behind Spore Works, one of the most trusted and long-standing spore suppliers in the mycology community. In this episode, I sit down with the legendary founders, John Workman and Robert Hess, to dive into the secrets that have made Spore Works a cornerstone of mushroom cultivation for over two decades.🔥 Here’s what you’ll learn in this episode: • The origins of the...2025-01-282h 53PCC Local TimePCC Local TimeAPMM Series: From Volunteer to Career: Evolving Fire Services in Northampton Township with Robert Pellegrino and Adam SeliskerIn this episode, we delve into the evolving relationship between a Township Manager and a Fire Chief, focusing on transitioning from a volunteer to a career fire service. This episode is a fascinating inside look at how a rural community that becomes a suburban one transitions from a volunteer to a full-time career fire service that includes volunteer fire. Robert Pellegrino and Adam Selisker share their journey, highlighting the importance of trust, community engagement, and strategic leadership. From addressing funding challenges to building a resilient fire service, this episode offers valuable insights for municipal leaders...2024-08-0853 minArt Lovers Forum PodcastArt Lovers Forum PodcastEpisode 21 - Robert Fontaine Thanks to Robert Fontaine, Lincoln Road is once again a meaningful and exciting destination for serious art collectors. He recently moved his blue chip art gallery, The Robert Fontaine Gallery, to the legendary outdoor mall, because of the ever-increasing foot traffic. It’s also steps away from the world-famous Art Basel and all of the art fairs that pop up annually. Robert Fontaine is going to add a certain new pizzazz to the area that he hopes will attract both new and experienced buyers who want blue chip art. Robert and his staff are more th...2024-07-1541 minNew In Chess PodcastNew In Chess Podcast#27. Robert Hess Fondly Remembers Miron Sher, Talks About Commentating And More!This week’s episode of the New In Chess Podcast features an interview with American grandmaster Robert Hess. A former US #5 with a peak FIDE rating of 2639, Robert is renowned as one of Chess.com’s star commentators, covering its largest events such as the World Chess Championship and the Candidates Tournament. Growing up in New York City, Robert showed promise in chess at an early age, but he credits his success to one man in particular: the late Soviet grandmaster and coach Miron Sher (1952-2020). Miron Naumovich Sher, together with his wife and son, emigrated from Ukra...2024-07-051h 00The Complete WorksThe Complete WorksThe Complete Works Ep. 104: Christopher Nolan – OPPENHEIMER (2023)The Complete Works Ep. 104 The Complete Works is a filmography podcast, brought to you by FilmBook. In each episode, FilmBook contributor Doug Hess reviews and analyzes a movie from film actor, actress, director, or composer's filmography. This week, Doug will dive into Christopher Nolan's 2023 film Oppenheimer. Cast Oppenheimer stars Cillian Murphy, Emily Blunt, Matt Damon, Robert Downey Jr., Florence Pugh, Rami Malek, Benny Safdie, Josh Hartnett, Dane DeHaan, Jack Quaid, Matthew Modine, Alden Ehrenreich, Jason Clarke, David Krumholtz, Kenneth Branagh, and David Dastmalchian. Plot Synopsis Oppenheimer (2023)’s plot synopsis: based on the book by Kai Bird and Martin Sherwin, “The movi...2024-06-2240 minThe Growth Guide: Self-Improvement | Greatness | Impact | Creators | FI |The Growth Guide: Self-Improvement | Greatness | Impact | Creators | FI |Navigating the Challenges of Technology and Change with Edward D HessEdward D. Hess is a Professor Emeritus of Business Administration at the University of Virginia and the author of 15 books, including “Hyper-Learning: How to Adapt to the Speed of Change.” Professor Hess had 20 years of experience as a business executive before joining academia. His research has mostly concentrated on achieving exceptional organizational and individual performance, specifically in the areas of leadership enhancement, fostering high-performance cultures, and designing learning and innovation platforms that facilitate superior human behavioral performance.Edward joined us today to talk about his new book, ‘OWN YOUR WORK JOURNEY!: The Path to Meaningful Work and Happin...2024-01-231h 18Texas Real Estate Radio NetworkTexas Real Estate Radio NetworkInterview With RMH (Reimer McGuinness Hess)Hello!RMH (Reimer McGuinness Hess) Cpas & Advisors Mike Huett & Randy Reimer713-590-3000 Please leave a review/like/subscribe to the show if you enjoyed! Thank You!!Please Like and Subscribe to our YouTube content - https://www.youtube.com/c/TheTexasRealEstateMastermindhttps://www.youtube.com/channel/UChDnEqEPO4BjHnCDcYGpFcwMr. Texas Real Estate is constantly striving to provide value to our community, and to help others grow and b...2022-12-2937 minStay hungry Podcast mit Robert HeinekeStay hungry Podcast mit Robert HeinekeDurch A/B Testes im E-Commerce über €50 Mio. zusätzlichen Umsatz generieren | Interview Samuel Hess→ Mehr Informationen zu drip agency: https://dripagency.de/ → Samuel auf LinkedIn folgen: https://www.linkedin.com/in/samuel-hess/ → Neues Training (30 Min) verfügbar: www.leadersmedia.de/journey → Erfahre alles über unser individuelles Mentoring: www.leadersmedia.de → Folge mir auf LinkedIn: www.leadersmedia.de/robert Stay Hungry ist der Podcast für ambitionierte Selbstständige und Unternehmer. Wenn du mit deinem Unternehmen digital wachsen oder sogar skalieren willst, dann ist dieser Podcast perfekt für dich. Der Podcast mit Robert Heineke richtet sich an ambitionierte Selbstständige und Unternehmer, die sich ein erfolgr...2022-09-281h 04Born to Talk Radio ShowBorn to Talk Radio ShowRobert HessThank you Robert Hess for joining me on the Born To Talk Radio Show Podcast. Robert Hess.   To begin with, Robert Hess graduated from the Virginia Military Institute, VMI. He was commissioned as a 2nd Lieutenant in the US Army in 1967.  Why did he choose VMI and the Army? He will be telling...2022-09-121h 02Perpetual Chess PodcastPerpetual Chess PodcastEP 282- 2022 FIDE Candidates Preview Double Episode with GM Robert Hess and Tai Pruce Zimmerman of the Chess by the Numbers BlogThe wait is almost over! With the 2022 FIDE Candidates Tournament beginning June 17, we present one last deep dive on this chess-history defining tournament. The winner of this tournament is slated to play GM Magnus Carlsen in the 2023 World Championship match if it takes place. I am joined by two separate guests to discuss the players and what we can expect. First up is GM Robert Hess. Robert, of course, is an insightful and popular commentator who will be traveling to Madrid to cover the event live with his Chess.com team. Robert and I discuss each player individually, as R...2022-06-072h 14Dr Robert Hess answers the latest questions on the pandemicDr Robert Hess answers the latest questions on the pandemicDr. Robert Hess : Long Covid After VaccinationMarch 2022 Website: www.drroberthess.com https://www.youtube.com/channel/UC5pB3gqEZKNL6FghFADy__w/featured2022-03-2306 minDr Robert Hess answers the latest questions on the pandemicDr Robert Hess answers the latest questions on the pandemicDr. Robert Hess: Managing the Covid-19 aftermath: Detox of the spike- proteinTwo full years after the pandemic began, it is now time to consider our next moves. In order to maintain a clear overview, Salvagene placed great emphasis on accurate documentation and ongoing information exchange right from the start. This meticulous approach, together with insights from science and research findings, enabled us to make precisely tailored recommendations for our clients. In the last few weeks and months, we have been gathering up loose ends and shifting our focus to appropriate preventive measures as well as preparations for the aftermath of the Covid-19 pandemic.2022-03-0910 minDr Robert Hess answers the latest questions on the pandemicDr Robert Hess answers the latest questions on the pandemicDr Robert Hess: Long Covid risk factors now identifiedAccording to the latest figures, between 10 and 30 percent of all persons who test positive for SARS-CoV-2 go on to develop long-term symptoms that can last for weeks, months or potentially even years. These can vary greatly depending on the severity of the disease, the age of the patient and his or her medical history. When – or indeed whether – those who suffer so‑called “Long Covid” can expect their symptoms to clear up is unclear, and there is as is as yet no treatment for the condition that does more than just alleviate symptoms. A U.S.-based research group has now identi...2022-02-1706 minSavage Perspective PodcastSavage Perspective PodcastBreaking the Cycle of Emotional Eating with Kristina HessDo you suffer from emotional eating? Growing up with a mother who had an eating disorder, Kristina Hess became interested in nutrition from an early age. When her mother got cancer, she made the decision to change careers and get into the health and nutrition space so she could help others avoid the issues her family faced. She is now the brains behind the Keto Symposium and offers a wealth of knowledge to her client base.2022-02-1158 minDr Robert Hess answers the latest questions on the pandemicDr Robert Hess answers the latest questions on the pandemicDr Robert Hess: Best medication yet? Paxlovid a potential game changerPaxlovid received emergency approval in the USA just before Christmas, and it may get the all-clear for use in Europe as early as January. This new medication could help reduce the number of people who fall severely ill with COVID-19, but supply shortages and manufacturing problems are so far hindering widespread distribution. Taken early enough after a diagnosis of COVID-19, paxlovid could dramatically reduce the risk of severe illness. Its manufacturer, Pfizer, claims that the likelihood of hospitalization or death for high-risk patients following an infection is reduced by almost 90 percent. Many in the medical profession are now hoping for...2022-01-2409 minDr Robert Hess answers the latest questions on the pandemicDr Robert Hess answers the latest questions on the pandemicDr Robert Hess: How do viruses – and more particularly SARS-CoV-2 – interfere with the p53 pathway?We look at the strategies employed by viruses against this tumor suppressor gene. Since the onset of the pandemic, research has been conducted into the extent to which SARS-Cov-2 affects the p53 tumor suppressor gene and its pathway. Two widely published studies from 2020 and 2021 have provided interesting insights into this, revealing the molecular strategies by means of which viruses such as SARS-CoV-2 target the p53 function. It is also interesting to compare the combat strategies of other viruses with those of SARS-CoV-2, and we will also briefly discuss this below.2021-12-2210 minDr Robert Hess answers the latest questions on the pandemicDr Robert Hess answers the latest questions on the pandemicDr Robert Hess: What next for the SARS-CoV-2 pandemic?The number of infections worldwide is on the increase, and with it, the number of vaccine breakthroughs. However, it is not only the rising rate of infection that is the root cause of this, but also the waning effect of the vaccines themselves. Nevertheless, individuals without any form of immunization are significantly less protected against COVID‑19 disease, and the mRNA booster jabs seem to be delivering on their promise of offering almost complete protection. There are multiple factors at play here that will continue to occupy our attention this winter. In the meantime, this is how we see the current si...2021-11-2412 minDr Robert Hess answers the latest questions on the pandemicDr Robert Hess answers the latest questions on the pandemicDr Robert Hess announces the flu season is just around the cornerWhat you need to know about the influenza season in general and high-dose vaccines in particular. Social distancing, face coverings and strict hygiene controls not only reduced the spread of SARS-CoV-2 last year but also of influenza viruses. Flu activity is currently still at a low level, but nonetheless slightly higher than at this time in previous years. Researchers and authorities in the USA and Europe are predicting that a particularly virulent wave of influenza will hit the northern hemisphere in the winter months of 2021/22 and are therefore advising senior citizens to get a shot of the relatively new high-dose...2021-11-1009 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Could the Novavax vaccine candidate be a viable alternative for skeptics wary of mRNA technology?Dr Robert Hess takes a look at new data on the protein-based inactivated vaccine. Many people who are skeptical of mRNA technology have been waiting for a conventional vaccine against coronavirus to come along. “Classic” vaccines are traditionally based on proteins. However, the one formulated by Novavax has a major disadvantage, specifically its ability to provide long-term protection against virus variants. On 10th October, scientists presented the results of a Phase 3 trial involving almost 30,000 adults resident in the USA and Mexico. In the preprint, they report an efficacy of 90.4 percent against symptomatic infection with SARS-CoV-2. In September, the New England Jour...2021-10-2604 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess uncovers the evidence that Delta does not make children more ill than other variants of the coronavirusThe Delta variant of coronavirus does not appear to lead to a more severe course of disease in children than earlier forms of the virus, such as the Alpha or Beta variants. This finding emerged from a prospective symptom study conducted in the UK, in which British school-aged children were compared for symptomatic COVID-19 courses over different time periods. Study results coming in earlier this year had already indicated that the Alpha variant of the SARS-CoV-2 virus does not appear to make children more ill than the “wild” form of the virus which first appeared in China. The prospective COVID-19 symp...2021-10-2502 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess: New relief for Migraine sufferers as FDA approves AbbVie’s QULIPTA (Atogepant)Towards the end of September, Chicago-based biotechnology pharmaceutical giant AbbVie announced that the FDA had approved its QULIPTA (Atogepant) medication for the preventive treatment of episodic migraine in adults. The FDA has thus given the green light to the first and so far only oral CGRP (calcitonin gene-related peptide) receptor antagonist specifically formulated for the preventive treatment of migraine. Peter J. Goadsby, professor at the University of California, Los Angeles, and at King’s College London, described the FDA approval of QULIPTA as a milestone in the treatment of migraine. Goadsby, who was awarded the prestigious Brain Prize in 2021 for hi...2021-10-1804 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Corona drug molnupiravir significantly reduces number of severe cases of disease and raises hopes, says manufacturerMerck Sharp and Dohme (MSD), the US pharmaceutical giant based in Kenilworth, New York, last week reported positive results from a Phase III trial of its new corona drug, molnupiravir. The manufacturer claim that it alleviates the course of the COVID-19 disease and halves the risk of hospitalization or death from a coronavirus infection. The potentially groundbreaking results promise a new way of treating COVID-19 and herald the first of hopefully many more antiviral drugs. Until now, COVID-19 has been treated with steroids such as dexamethasone and intravenous antibodies (MAB). Both are administered to patients who are already extremely ill...2021-10-1406 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?FDA approves booster dose of Pfizer-BioNTech vaccine but not yet for the wider populationThe issue of booster vaccination has risen high on the agenda, and every country is taking a different approach to it. Israel, Austria and Russia are already offering booster jabs to the general population, whereas Belgium, the United Kingdom, Denmark, Finland, France, Ireland, Italy, Spain and Sweden are restricting them to the immunocompromised or elderly. Germany will reach its own national decision in early October, and in the United States, the FDA announced last week that it had approved boosters, albeit on a more restrictive basis than had been expected.2021-09-3007 minStadt. Land. Schwul.Stadt. Land. Schwul.OnlyFansDie queere Sicht auf die heutige Zeit. Das Herz auf der Zunge wie das Gemächt im Jockstrap. Endlich kann die Katze aus dem Sack! Stadt.Land.Schwul. does OnlyFans. Was wir genau machen und mit wem erfahrt ihr in der heutigen Folge. Wir sprechen über die Platform die in den letzten Wochen sehr in den Medien stand. Freut euch auf eine tolle Folge und einen tollen Gast Content Creator und Porno Star Robert Royal! Der sexy, heiße, liebe & gut aussehende Robert Royal wird uns alle Fragen beantworten und erzählt uns aus seinem Nähkästchen. Also wir li...2021-09-241h 11Dr Robert Hess answers the latest questions on the pandemicDr Robert Hess answers the latest questions on the pandemicDr Robert Hess: new concepts such as antibody therapy and vaccination by inhalation against COVID-19 infectionCurrent status and news of new concepts such as antibody therapy and vaccination by inhalation against COVID-19 infection. We at Dr Robert Hess's Task Force have a special interest in this topic, because for some of our premium members the conventional vaccination against Covid-19 is not an option or even can be counterproductive. We see these new concepts as possible solutions for additional protection against coronavirus infection without the need for vaccination. In certain cases, monoclonal antibodies (MAK) are considered to be a promising drug against severe disease progression in SARS-CoV-2 infection and have been used in the clinical setting...2021-09-1707 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess gives update on new mutations and what you need to know about COVID-19 variantsAs experts in the field of human and molecular genetics and thus also on the topic of mutations, Dr Robert Hess provides regular updates and forecasts of where the pandemic might be heading. Recently, new discoveries have come into the frame, so we have summarized these findings for you and added our own assessment. Several thousand COVID-19 variants exist around the world, but most of them do not change the way the virus acts. So far, only a few mutants have evolved from the original strain that have given the virus an advantage and accelerated the course of the pandemic...2021-09-1705 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess about CureVac: Modified vaccine developed in collaboration with GSK is in preclinical testingCureVac's first-generation vaccine candidate CVnCoV unfortunately fell by the wayside in mid-June after failing to meet the statistical criteria for success, but there is now news regarding a modified second-generation vaccine candidate, which CureVac has developed in collaboration with British pharmaceutical giant GSK. Back in February of this year, CureVac and GSK announced a €150 million joint project with the primary objective of developing multivalent vaccine candidates against viral variants. The initial preclinical data for the second-generation vaccine candidate, CV2CoV, was published in May, with the prospect of clinical trials commencing in the third quarter of this year. However, this ta...2021-09-1703 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess comments about recent studies relating autoantibodies against interferon-I and a SARS-CoV-2 infectionDoctor Robert Hess comments about recent studies that have established a strong link between the presence of autoantibodies against interferon-I and a severe progression of disease after infection with SARS-CoV-2. As we have explained in previous Keynotes, our body’s own interferon system plays an important role in the activation and modulation of the immune defenses. In this update, we will focus on what happens when there is a failure to activate the type I interferons (IFN-I) and on the risks that this poses. IFN-I is of immense importance in relation to the body’s own virus defense and thus highl...2021-09-1703 minDr Robert Hess answers the latest questions on the pandemicDr Robert Hess answers the latest questions on the pandemicDr Robert Hess speaks about the FDA grants full approval to the Pfizer/BioNTech COVID-19 vaccineWhat exactly does full FDA approval of a vaccine mean? The Pfizer/BioNTech COVID-19 vaccine first received Emergency Use Authorization (EUA) from the U.S. authorities in mid-December 2020 for administration to persons aged 16 and older. On Monday, the FDA announced that it has now granted full approval. The vaccine has thus become the first to receive FDA approval for use against coronavirus. More are expected to follow in the coming weeks and months. Emergency Use Authorization continues to apply for use on adolescents aged 12 to 15 years and for administration as a third booster dose to immunocompromised individuals. Further monitoring of...2021-09-0604 minDr Robert Hess answers the latest questions on the pandemicDr Robert Hess answers the latest questions on the pandemicDr Robert Hess questions booster jab or next-generation vaccine?August 2021 Website: www.drroberthess.com https://www.youtube.com/channel/UC5pB3gqEZKNL6FghFADy__w/featured2021-09-0204 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess: Differing opinions about the Lambda variant: Super mutant, successor to Delta or damp squib?For the first time since the Salvagene SARS-CoV-2 Task Force was established 18 months ago, a difference of opinion has arisen, specifically with regard to the Lambda variant. What everyone agrees on is that the Lambda or C.37 variant is clearly more contagious than the original Wuhan strain. In addition, it is much more resistant to antibodies, and the existing vaccines therefore have a reduced efficacy against it. The reason for this is three mutations in the spike protein, which render it less susceptible to neutralization by antibodies. Added to which there are two mutations that make the variant itself more...2021-09-0216 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?As Doctor Robert Hess expected, the pandemic is becoming more complex and problematic in natureJuly 2021 Website: www.drroberthess.com https://www.youtube.com/channel/UC5pB3gqEZKNL6FghFADy__w/featured2021-09-0214 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess skepticism regarding the efficacy of all previous vaccines against the Delta variant has been confirmedDr Robert Hess skepticism regarding the efficacy of all previous vaccines against the Delta variant has been confirmed by the announcement from BioNTech/Pfizer that they are working on a vaccine that will specifically target this mutant. So far, we have been testing only one of the two immunity pillars, namely antibody production. In addition to checking the full range of antibodies, we at Salvagene go far beyond the generally applied classification to differentiate between the neutralizing antibodies and identify efficacy classes – low, medium and high – plus ADE antibodies which may even have the undesired effect of amplifying an infection. From...2021-09-0211 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess: The SARS-CoV-2 T-Cell immunity analysis is to be integrated into the Covid-19 Immunization ProgramThe SARS-CoV-2 T-Cell immunity analysis is to be integrated into the Covid-19 Immunization Program for Salvagene Premium clients with immediate effect. So far, we have been testing only one of the two immunity pillars, namely antibody production. In addition to checking the full range of antibodies, we at Salvagene go far beyond the generally applied classification to differentiate between the neutralizing antibodies and identify efficacy classes – low, medium and high – plus ADE antibodies which may even have the undesired effect of amplifying an infection. From now on, we will also be measuring the second Covid-19 immune pillar – namely T cell immuni...2021-09-0206 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess: CureVac were our great hope. They reached for the stars – and came back down with a bump.Though the news was not entirely unexpected, we regret to report that the breakthrough vaccine promised by CureVac will now not be forthcoming. There are a number of reasons for this, but the main factor was the high demands that CureVac itself placed on the product. The aim was to develop a vaccine that was as natural as possible – ideally the most natural vaccine to date. In the end, it was the much-debated issue of vaccine-induced side-effects and long-term effects that thwarted their endeavor.2021-09-0202 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Doctor Robert Hess questions how long does the protection afforded by vaccination last?This is a vital question that can only be answered when enough time has elapsed for results to come in. There is one thing we can be certain of, however, namely that the protection afforded by vaccines does not live up to the claims made by their manufacturers. We strongly disagree with the assertion that “vaccine protection will remain at the same high level for approximately one year, so that we can get into an annual vaccination cycle like the one we have for influenza.” This is the reason why we set up our SARS-CoV-2 Antibody Profile Monitoring for Premium clie...2021-09-0210 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr. Robert Hess: The Delta variant is not the dreaded super mutant, but it may be a game-changer in a negative sense.In India, the Delta variant has been responsible for a sharp increase in the number of infections, illnesses and fatalities. The health system there is at breaking point. In the meantime, the Delta variant has also been discovered in other parts of the world, especially in the UK, which is a country where virus variants are monitored with exemplary thoroughness. It is expected that the Delta variant will supplant Alpha (B.1.1.7), which has been the most widespread variant so far. According to official data, Delta is currently present in nine out of ten samples sent for analysis.2021-09-0207 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess: We are now several months into the vaccination campaign, and it is clear to us from our own SARS-CoV-2..... SARS-CoV-2 antibody and immunization testing that the track record of the vaccines is very disappointing, with more side-effects than originally expected. We therefore intend to have a personalized vaccine combination in place for 2022. In contrast to the phase 3 data published by the various vaccine manufacturers, some of which claim headline rates of more than 90% efficacy, the test results that have come back from our clients indicate none of the vaccines has achieved this sort of success. Based on the clinical data and biochemical evaluations that we carry out at regular three-monthly intervals, we conclude that the levels actually attained are...2021-09-0216 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess and his Task Force: On 30th March 2021, the WHO Commission of Inquiry issued a statement......to the effect that a laboratory accident as the cause of the pandemic was “extremely unlikely”. The skepticism we expressed at the time about their findings is now being vindicated. At the time, we came in for considerable criticism for our assessment that the probability of a laboratory accident having released the virus was around 60%, and we were even accused of stirring up a conspiracy theory.2021-09-0211 minRecruiting InsightRecruiting InsightInterview with Robert Gideon IISend us a textRobert Gideon, Owner of NextHome Central Real Estate in Oklahoma City, joins the podcast to share his experience building a real estate business from the ground open and juggling business operations with recruiting objectives. Robert and Ben also discuss the strategies that have produced success with both new and experience agent recruiting and how ThirdPool and CoRecruit have contributed to that success.You can engage with other Recruiting Insight content by visiting https://recruitinginsight.usYou can also learn more about ThirdPool Recruiting by navigating to https://thirdpool.com2021-08-2719 minUniversity of Illinois Press Podcast SeriesUniversity of Illinois Press Podcast SeriesDr. Robert Sampson, the Journal of the Illinois State Historical SocietyDr. Robert Sampson, the Journal of the Illinois State Historical Society by Elizabeth Hess2021-08-2519 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess gives statement about the miracle of Madrid: Rapid antigen testing as a game changer.In our series on smart solutions for managing the coronavirus crisis, Dr Robert Hess has frequently reported on C19 rapid antigen testing, and he has explained how this technology has the potential to be a real game changer in the context of the Covid-19 pandemic.2021-08-2006 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Doctor Robert Hess and his SARS-CoV-2 Task Force: Flu in the time of SARS-CoV-2 – or maybe it’s just a cold?With the onset of the flu season, it is vital to correctly diagnose symptoms to establish what kind of infection they indicate. We explain below why this is so important. During the flu season, we are exposed to a whole range of different viruses, of which SARS-CoV-2 is currently the greatest cause for concern. The four most important virus types in this flu season also include the coronaviruses responsible for triggering the common cold, the influenza viruses which cause flu and the noroviruses responsible for gastrointestinal infections. It is very important to distinguish and diagnose which disease you may be...2021-08-1909 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess explains how you can avoid SARS-CoV-2 damaging your body’s own interferon systemOctober 2020 Website: www.drroberthess.com https://www.youtube.com/channel/UC5pB3gqEZKNL6FghFADy__w/featured2021-08-1910 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Three different perspectives by Dr Robert Hess on the Covid-19 pandemic.The current pandemic can be viewed from three distinct perspectives: 1. Epidemiological: Research by epidemiologists around the world is gradually leading to a consensus view of the measures that are required to tackle the virus. 2. Economic: This is driven by the decisions taken during the pandemic. It is of utmost importance that any strategy for dealing with the pandemic is effective and that collateral damage to the economy is not unnecessarily severe. Political considerations are a major factor here. 3. Individual: This third personal perspective may not always coincide with that of society as a whole, in which the priority has to...2021-08-1808 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess questions how dangerous is SARS-CoV-2 in combination with the Influenza virus?September 2020 Website: www.drroberthess.com https://www.youtube.com/channel/UC5pB3gqEZKNL6FghFADy__w/featured2021-08-1810 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess gives statement about cardiological consequences of asymptomatic or mild cases of Covid-19.As we have already reported in our WhatsApp broadcast, an examination of the genetic mutations in the various types of SARS-CoV-2 virus currently circulating in the world reveals two trends. On the one hand, the viral load is in some cases significantly higher than before because of these mutations, and as a result the viruses are easier to catch, as can be seen from the sharp increase in the number of cases being reported. On the other hand, the multiplicity of mutations observed suggests that the number of very severe Covid-19 cases is decreasing and that the mortality rate is...2021-08-1805 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr. Robert Hess comments long-term damage from Covid-19: The neurological consequences.The one place in the body where the virus cannot be shaken off. Fatigue, headaches, strokes – SARS-CoV-2 also causes serious damage in the brain. It has now been proven that the virus can cross the blood-brain barrier and even infect unborn babies. How can it be stopped?2021-08-1809 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess discusses the fears of a cytokine storm resulting from a future C-19 vaccination.August 2020 Website: www.drroberthess.com https://www.youtube.com/channel/UC5pB3gqEZKNL6FghFADy__w/featured2021-08-1809 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Long-term damage caused by Covid-19: Pathologists document a battlefield in the heart muscle cells, a gaping wound.We have previously reported on the long-term damage that results from Covid-19, and examinations conducted by pathologists are providing an especially rich source of information confirming this. Some time ago, we wrote about a study at UKE in Hamburg, which is looking at the effect on various organs. In this Keynote, we will address the issue of long-term cardiovascular damage.2021-08-1708 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?New C-19 Vaccine and Medication Advisor Tool by Dr Robert HessGam-Covid-Vac is a joint project between the Russian Ministry of Defense and the internationally little-known Gamaleya Research Institute of Epidemiology and Microbiology. Starting on 20th August, the world’s first vaccine against Covid-19 will be widely distributed for use on the general public. The first large-scale trials began some time ago on thousands of military personnel as well as doctors and teachers. The decision has now been taken to extend it to the entire population.2021-08-1711 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess comments corona clusters: Aerosols: The invisible danger in enclosed spaces.June 2020 Website: www.drroberthess.com https://www.youtube.com/channel/UC5pB3gqEZKNL6FghFADy__w/featured2021-08-1704 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess gives statement about corona clusters: How just a few “super spreaders” keep the pandemic going.Many people who catch the coronavirus manage to avoid infecting anyone else. The disease is mainly spread by just a few individuals. In this podcast, we explain what makes these individuals so infectious and the significance of the k factor.2021-08-1704 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Important note for Dr Robert Hess premium members about hydroxychloroquine.May 2020 Website: www.drroberthess.com https://www.youtube.com/channel/UC5pB3gqEZKNL6FghFADy__w/featured2021-08-1703 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr. Robert Hess talks about the quest for new weapons to combat Covid-19.In our first podcast, we present some of the new technologies behind potential Covid-19 therapies to complement the solutions already outlined in our Keynote series. We see them as, at best, a bridging solution while we wait for a future vaccine to become globally available.2021-08-1715 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Still too soon for individual recommendations from Dr Robert Hess on vaccination.Unfortunately, it is still too soon for us to be making individual recommendations on vaccination. This is mainly because we do not recommend that our clients volunteer to be among the first 1-2 million recipients of any particular vaccine, as experience has shown that this is the stage at which adjustments to dosage take place and any unwanted side-effects generally manifest themselves.2021-08-1709 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Recommendations made by Dr Robert Hess are increasingly being adopted by major medical organizations.Medical associations such as DEGAM (Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin) in Germany have been adopting the same recommendations we have been making to our Premium clients since May as part of our Covid-19 Immunization Program and have developed their own individual measures based on this strategy.2021-08-1707 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr. Robert Hess asks, is now the time to get vaccinated?The wider interests of society in combating the pandemic and the interests of the individual have not yet converged. What is best for society in its efforts to control the pandemic may not necessarily coincide with what is best for the individual.2021-08-1708 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess gives individual recommendations for his Premium customers in the USA regarding the Covid-19......antibody medication from Eli Lilly. Numerous active substances have so far been tried out against the virus. Once they have been officially approved for use, we look at their pharmacogenetic profile to decide whether they offer individual efficacy for our Salvagene Premium clients over and above the standard range of efficacy that is determined in the course of the official approval process. It has to be said that, apart from the cortisone preparation dexamethasone, there is no really convincing treatment for patients suffering from the effects of Covid-19. As we have been reporting for some months now, our best hopes...2021-08-1708 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Individual recommendation regarding the BioNTech vaccine for Dr. Robert Hess Premium clients in the USA.With the announcement by the FDA last Friday evening (11th December) that they had given emergency approval for the vaccine developed by the Mainz-based BioNTech company and manufactured by its commercial partner Pfizer, we are now able to make initial and preliminary recommendations to Dr Robert Hess Premium clients in the USA.2021-08-1706 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Information for Dr. Hess Premium clients in Europe: EU likely to begin vaccine roll-out on 27th December.The first Covid-19 vaccine in the Western world, which was developed by BioNTech in Germany, was granted emergency approval in the UK, USA, Canada and other countries several days ago. It is therefore no surprise that political pressure has been growing in Europe in response to the obvious question why a vaccine developed in Germany is not also available in the member states of the European Union.2021-08-1704 minDr Robert Hess answers the latest questions on the pandemicDr Robert Hess answers the latest questions on the pandemicAccording to Dr Robert Hess, there is In the center of the pandemic's interest: The interferons and their receptorsWhen we first launched our Salvagene COVID-19 Immunization Program in April 2020, our SARS-CoV-2 Task Force decided to incorporate testing of the interferons and their receptors, both analytically and more specifically epigenetically.2021-08-1019 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess: Covid-19 disease and the two key areas of genetics.We at Salvagene have been specializing in the field of genetics for more than 20 years, and it now constitutes our core competence. We are therefore looking at the coronavirus pandemic and the Covid-19 disease from a genetics-based perspective, and we regard it as a matter of utmost priority.2021-07-1909 minDr Robert Hess answers the latest questions on the pandemicDr Robert Hess answers the latest questions on the pandemicDr Robert Hess, the founder of Salvagene, about Covid-19 immunization possibilities.2021-07-1929 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess speaks about mRNA vaccines:Genetic information that instructs human cells to produce a fragment of the virus. Despite the fact that research in the field of mRNA has been going on for 30 years now, not a single medication based on this technology had succeeded in getting past the approval stage until the EMA authorized its use a few days ago.2021-07-1804 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess and his SARS-CoV-2 Task Force: As we have long maintained, the direction taken by the pandemic ...will be determined by the genetics of the SARS-CoV-2 virus itself. The prospects for success in defeating the pandemic in 2021 are therefore uncertain. SARS CoV-2 Task Force: As we have long maintained, the direction taken by the pandemic will be determined by the genetics of the SARS CoV-2 virus itself. The prospects for success in defeating the pandemic in 2021 are therefore uncertain.2021-07-1809 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?The important work being done by sequencing laboratories in monitoring the virus -Dramatic development in long-term effects from Covid-19 – Individual recommendations on vaccination for Dr. Hess premium clients. We have been predicting for some time now that SARS CoV-2 would mutate and evolve. From the variants that have since emerged – in particular B.1.1.7. and 501Y.V2 – it is clear that central monitoring of new variants as they arise, similar to that for influenza viruses, has a vital role to play in ensuring better management of the pandemic. It is also important for us in the work we do advising our clients on vaccination.2021-07-1605 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?UK imposes entry bans on passengers from Brazil and various other South American countries... following further mutations in the SARS-CoV-2 virus – Dr. Hess reserves judgment on vaccination. The eyes of the entire scientific world are currently fixed on two countries: on the one hand, Israel, which has achieved the highest per capita vaccination rates and could therefore provide valuable lessons in terms of vaccine rollout, effectiveness, infectivity and herd immunity; and on the other, Brazil, specifically because of the SARS CoV-2 gene variants discovered there, which have led the British government to impose entry bans from the South American continent and from Portugal.2021-07-1608 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess and his SARS-CoV-2 Task Force one year on.Doctor Hess introduces infection and vaccination log for Premium Clients. This last year has gone by surprisingly fast for us, and it seems like only yesterday that we were putting our team together. Almost six weeks before the World Health Organization declared the pandemic, the data we had already received from Asia prompted us to react at a relatively early stage. It was a very busy time for us, during which we learned a lot. Looking back at all of our communications with you during these past 12 months, we have published around 100 Keynotes and at least as many podcasts. They...2021-07-1421 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess gives statement: The mutants chance everything.Right from the start, SARS CoV-2 has measured up to the two main criteria of a model pandemic virus: it spreads easily and kills only a small percentage of those infected. However, new mutant forms have produced a new twist in the plot. It comes as no surprise to us that the goalposts have been moved in favor of the virus.2021-07-1412 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess adds tocilizumab to its official list of recommended Covid-19 medications.February 2021 Website: www.drroberthess.com https://www.youtube.com/channel/UC5pB3gqEZKNL6FghFADy__w/featured2021-07-1304 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Internal study by Dr Hess: For individuals with a perfect immune response, the benefits ...... of vaccination are minimal to zero. This internal study involved Dr Robert Hess Premium clients who have subscribed to our Covid-19 Immunization Program since April 2020, who have a Covid-19 Risk Factor of 2021-07-1309 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess admits that filtering out fake news and misinformation regarding health maintenance, ...... vaccines and optimization of the immune system is becoming an increasingly uphill challenge. Dr Robert Hess SARS-CoV-2 Task Force was set up in January 2020 with the aim of providing his Premium clients with the best possible service during the current pandemic by critically evaluating information on SARS-CoV-2, filtering out the irrelevant and/or misleading and communicating the results. It is a job that has become increasingly difficult.2021-07-1216 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess launches the world’s most comprehensive SARS-CoV-2 antibody profile monitoring service.March 2021 Website: www.drroberthess.com https://www.youtube.com/channel/UC5pB3gqEZKNL6FghFADy__w/featured2021-07-1209 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?The probability that the pandemic will be with us for the longer term has increased significantlyNew strategy emphasis for Dr. Hess clients group in 2022. Dr Robert Hess considers that the likelihood of a major vaccine campaign bringing the pandemic to an end this summer is diminishing. With this long-term scenario in prospect, we at the Salvagene Group have had a strategic rethink, not least because we have been allocating so much of our resources to SARS-CoV-2 research over the past twelve months. We now intend to significantly expand capacity in our core expertise, namely cancer prevention, to avoid a situation where this priority is repeatedly pushed to one side. We have to work on the...2021-07-1112 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?All vector-based vaccines to be kept under review by Dr Hess.We are not surprised by the latest developments surrounding the current crop of vaccines and the problems that have arisen, especially with regard to AstraZeneca. Since April 2020, we have repeatedly pointed out shortcomings in the design of the pivotal study, the results of the efficacy study and even fundamental design flaws in the vaccine.2021-07-1110 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess questions what next for vector-based vaccines? Vector-based vaccines on the way out?Since posting our previous podcast in which we detailed our concerns about vector-based vaccines – more specifically AstraZeneca – as the possible cause of thrombosis, more material has come to hand explaining why there are significant though rare side-effects, including death. These concerns have led to many countries restricting the use of the AstraZeneca vaccine, at least for certain age groups. They have taken this decision despite the European agency, EMA, standing by its continued unrestricted approval. The relevant materials include records of thrombosis cases, including the incidences of sinus vein thrombosis that are of special interest for us.2021-07-0911 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Hess asks: What next for younger people who have had only the first of two AstraZeneca jabs now that ...... the rollout to their age group has been halted? Are vector-based vaccines really on the way out? As Dr Robert Hess mentioned, hundreds of thousands of young men and women have already received their first shot of the AstraZeneca vaccine. How to proceed next is a question that is preoccupying health authorities throughout the EU as well as in other first-world countries such as Australia and Canada.2021-07-0913 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess gives statement: Politicians overstep the mark with moves to impose a total ban on vector-based vaccines.Dr Robert Hess thinks that the lobbying power of the various pharmaceutical manufacturers – especially in Washington, Brussels and Amsterdam – will prove strong enough to ensure the continued deployment of vector-based vaccines. The industry is able to make a convincing case that these vaccines are needed, especially in Third World countries. Firstly, because AstraZeneca is a very cheap vaccine to store and secondly because only a single dose of Johnson & Johnson has to be administered. These vaccines are therefore a good solution for countries with poor infrastructure.2021-07-0808 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess wonders: Fully vaccinated, so where do we go from here?We view with concern policy statements emanating from various health authorities around the world regarding national testing strategies and whether these are to be applied to the vaccinated population. It has been suggested by both the Centers for Disease Control and Prevention (CDC) in the USA and the Robert Koch Institute (RKI) in Germany that vaccinated persons might be exempted from testing arrangements. We are very much opposed to any such policy because of the consequences it would have for the behavior of those who are vaccinated and for our Premium clients.2021-07-0709 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess SARS-CoV-2 and his Taks ForceBiotech SMEs win hands down against big pharma in the race to develop vaccines. A word of caution to our Premium clients: Anyone in recovery from Covid or suffering from Long Covid needs to take precautions against aspergillus spores.2021-06-2710 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Calling all Premium clientsMay 2021 Website: www.drroberthess.com https://www.youtube.com/channel/UC5pB3gqEZKNL6FghFADy__w/featured2021-06-2411 minDr Robert Hess - Ready for the battle?Dr Robert Hess - Ready for the battle?Dr Robert Hess asks: At what stage will we be able to declare the pandemic over?Dr Robert Hess aims to maximize immunity levels in his clients for the event that they become infected with SARS-CoV-2. He also keeps his clientele informed about the latest developments in the pandemic and offers a personalized vaccination strategy on an ongoing basis.2021-06-1711 minA Breath of Fresh CareerA Breath of Fresh CareerThe 3rd Party "Cookie Monster" has left the building! A Breath of Fresh Career interview with Robert HessA Breath of Fresh Career S2, E9 Robert Hess InterviewIn this episode, Robert and I discuss Cookies and how they are used to target consumers. Many people don’t know the difference 3rd party cookies and 1st party cookies and how they affect and influence our lives and online experience. Robert is a wealth of knowledge when it comes to data and technology which he developed in his early career selling traditional newspaper advertising. Connect with Robert here: https://www.linkedin.com/in/roberthess/ or Email him here: info@maromapartners.com2021-05-1449 minEpisode 202: You Can’t Spell Chess without HessTom and Joe sit down with Robert Hess, a Chess Grandmaster about the growth of Chess from a digital platform, including Twitch. They keep relating to The Queen’s Gambit, the Netflix hit show to draw parallels (excluding the green pills). Beginning at 8 years old, Robert started to progress his skills at chess including traveling abroad for tournaments and the work he had to put in to balance his schoolwork and chess mastery. At the age of 17, he was named a Chess Grandmaster, before going to study at Yale and his connection to Overtime. Today he commentates for Chess.com an...2020-11-191h 05Episode 202: You Can’t Spell Chess with HessTom and Joe sit down with Robert Hess, a Chess Grandmaster about the growth of Chess from a digital platform, including Twitch. They keep relating to The Queen’s Gambit, the Netflix hit show to draw parallels (excluding the green pills). Beginning at 8 years old, Robert started to progress his skills at chess including traveling abroad for tournaments and the work he had to put in to balance his schoolwork and chess mastery. At the age of 17, he was named a Chess Grandmaster, before going to study at Yale and his connection to Overtime. Today he commentates for Chess.com an...2020-11-191h 05The CUSP ShowThe CUSP ShowEpisode 202: You Can’t Spell Chess without HessTom and Joe sit down with Robert Hess, a Chess Grandmaster about the growth of Chess from a digital platform, including Twitch. They keep relating to The Queen’s Gambit, the Netflix hit show to draw parallels (excluding the green pills). Beginning at 8 years old, Robert started to progress his skills at chess including traveling abroad for tournaments and the work he had to put in to balance his schoolwork and chess mastery. At the age of 17, he was named a Chess Grandmaster, before going to study at Yale and his connection to Overtime. Today he commentates for Chess.com an...2020-11-191h 04Cover Stories with Chess LifeCover Stories with Chess LifeCover Stories with Chess Life #13: GM Robert HessThe April 2019 edition of “Cover Stories with Chess Life” is now live! This monthly podcast, hosted by Senior Director of Strategic Communication Daniel Luc This month, we talk to GM Robert Hess, our "In the Arena" columnist and the author of this month's cover story about Hikaru Nakamura's Grand Chess Tour triumph. Hess is also a popular online commentator and Twitch streamer. “The Skittles Room” is our monthly segment in which we talk to people doing something interesting or of note within US Chess. Natasha Roberts, our Creative Content Coordinator at US Chess, talks about the changes she has imp...2020-11-1454 minProsperous Coach PodcastProsperous Coach Podcast4: How to Feel Less Isolated in Your Coaching BusinessThere are so many upsides to having your own business. But the biggest downside to operating as a solopreneur is that you're ... well, solo.That is, unless you do something intentional to change that. And I'm hoping that after this podcast you will take some action so you don't feel lonely in your business.Being an entrepreneur is different than any job you've ever had. At first you're slogging through tasks without a team, a sounding board or even a water cooler connection.Soon, you will have a steady flow of coaching clients...2018-12-0319 minCoffeehouse BlundersCoffeehouse BlundersChess Grandmaster Robert Hess TakeoverChess Grandmaster Robert Hess joins Danny (while James is off traveling the world) to review everything that was the 2018 World Chess Championship match between Magnus Carlsen and Fabiano Caruana. Follow Us Danny: Twitter, Twitch, Chess.com Motz: Twitter, Blog, GitHub Music : Amethyst Seer - Ouija by Adventureface Proudly recorded on Zencastr ⭐⭐ Review Us ⭐⭐ Support the Show: Subscribe to Blue Bottle and Get $10 Become a Chess.com Member and Support Blunders Special Guest: Robert Hess.Links:World Chess Championship 2018: Carlsen vs Caruana - Chess.comGarry Kasparov on Twitter: "In light of...2018-11-2932 minWorld of Motorcycling PodcastWorld of Motorcycling PodcastWOM EP24 Robert Hess Interview & More 032118We kick off the show with the latest happenings in the world of motorcycling beginning with Teamsters verses Harley-Davidson as they seek to keep Harley-Davidson Plant open. We cover a number of other things including BRP Sales, S&S new hire and so much more. We also discuss the latest trends coming out of the Motorcycle World including a Val Thompson Crash and Start of Moto GP. Up next we bring on Robert Hess founder of The Tour de USA a very cool cross country rally to raise awareness of Prostate Cancer and to bring fellow enthusiasts together for a...2018-03-2258 minPerpetual Chess PodcastPerpetual Chess PodcastEP.40 - Grandmaster Robert HessGM Robert Hess is this week's guest on Perpetual Chess. Young GM Hess already has loads of experience as a chess competitor, announcer, and coach. (He coached some of the most talented youth for the U.S. as well as the women's Olympiad team.) We talk about all of these things, as well as the FIDE World Cup, sports, and whether or not he was a "rival" of Fabiano Caruana when they were both top scholastic players from New York. Follow GM Hess on twitter here, and on chess.comhere. See omnystudio.com/listener for privacy information. 2017-09-191h 18Who Are You: The Life Lessons of SportsWho Are You: The Life Lessons of Sports97: Jim Hess, Western Michigan Women's Basketball Head Coach (former) And Father Of Two Professional Baseball Players, Shares A Wealth Of Sports Experience As An Athlete, Coach, Mentor & FatherJim Hess shares decades of coaching experience after a successful journey playing athletics growing up and through college. Jim was the head coach of the Western Michigan Women's Basketball Team for close to 8 years and led the Broncos to their first ever Mid-American Conference Championship and NCAA Tournament berth. Jim has also been a coach and a sponsor of organizations that include: Westwood Little League, AYSO Soccer, and YMCA basketball.  He serves on the Board of Directors for the Kalamazoo Education Foundation, Maroon Foundation for Kalamazoo Central High School and is the past President of the Kalamazoo C...2014-06-2449 minHess Collection Audio TourHess Collection Audio TourRobert RauschenbergDonald Hess on Rauschenberg's overnight fame2013-04-1002 minHess Collection Audio TourHess Collection Audio TourRobert RauschenbergSuccessful ArtistWho says artists only become famous after death? Many artists are successful markers of themselves. Robert Ceballos discusses this notion.2013-04-1001 minHess Collection Audio TourHess Collection Audio TourRobert RauschenbergDiversityRobert Raushenberg in search of diversity and continual artistic investigations. Director, Robert Ceballos talks about conceptual art and the beauty of functional form in every day disposable objects.2013-04-1001 min